Valuation: Harbin Pharmaceutical Group Co., Ltd.

Market Cap 13.37B 1.97B 1.73B 1.6B 1.47B 2.78B 190B 2.82B 19.13B 7.5B 93.18B 7.42B 7.25B 321B P/E 2026 *
29.5x
P/E 2027 * 25.3x
Enterprise Value 13.37B 1.97B 1.73B 1.6B 1.47B 2.78B 190B 2.82B 19.13B 7.5B 93.18B 7.42B 7.25B 321B EV / Sales 2026 *
0.82x
EV / Sales 2027 * 0.79x
Free-Float
47.74%
Yield 2026 *
-
Yield 2027 * -
1 day-0.38%
1 week+57.57%
Current month+77.59%
1 month+72.40%
3 months+27.34%
6 months+51.28%
Current year+53.91%
1 week 3.64
Extreme 3.64
5.57
1 month 2.84
Extreme 2.84
5.57
Current year 2.84
Extreme 2.84
5.57
1 year 2.84
Extreme 2.84
5.57
3 years 2.41
Extreme 2.41
5.57
5 years 2.41
Extreme 2.41
5.57
10 years 2.38
Extreme 2.38
9.77
Manager TitleAgeSince
Chief Executive Officer 64 2023-12-26
Director of Finance/CFO 54 2004-12-23
Investor Relations Contact 45 2022-04-26
Director TitleAgeSince
Director/Board Member 60 2021-01-07
Chairman 56 2023-12-26
Director/Board Member 46 2022-06-26
Date Insider Type Main position Quantity % Market Cap.
7/1/24 Sell 36,000 0.0014%
7/1/24 Sell

Chief Financial Officer

90,000 0.0036%
7/1/24 Sell 27,000 0.0011%
Change 5-day change 1-year change 3-year change Capi.($)
-0.38%+57.57%+34.43%+63.89% 1.98B
-2.73%-2.96%+48.62%+147.27% 1,051B
-1.67%-3.47%+52.00%+47.77% 609B
-0.44%+2.17%+33.88%+78.20% 450B
-0.75%+0.30%+28.32%+21.15% 330B
-1.52%-1.19%+33.38%+35.35% 284B
-1.70%-1.82%+20.26%+15.74% 263B
-0.58%+1.11%-20.89%-40.59% 223B
-0.58%+1.03%+23.55%+56.14% 198B
-0.80%+1.38%+23.09%+66.64% 167B
Average -0.72%+2.87%+27.66%+49.16% 357.7B
Weighted average by Cap. -0.89%-1.06%+35.25%+70.88%

Financials

2026 *2027 *
Net sales 16.4B 2.42B 2.12B 1.96B 1.8B 3.41B 234B 3.46B 23.47B 9.2B 114B 9.1B 8.9B 394B 16.94B 2.5B 2.19B 2.03B 1.86B 3.52B 241B 3.57B 24.23B 9.5B 118B 9.39B 9.19B 407B
Net income 452M 66.76M 58.52M 54.09M 49.75M 93.86M 6.44B 95.37M 647M 254M 3.15B 251M 245M 10.85B 520M 76.85M 67.36M 62.26M 57.26M 108M 7.41B 110M 745M 292M 3.63B 289M 282M 12.49B
Net Debt - -
Logo Harbin Pharmaceutical Group Co., Ltd.
Harbin Pharmaceutical Group Co Ltd is a China-based company mainly engaged in the research and development, manufacturing, wholesale and retail of pharmaceutical. The Company is mainly engaged in two businesses. The pharmaceutical industry business is mainly engaged in the research, development and manufacturing of chemical raw materials, chemical preparations, biological preparations, traditional Chinese medicine and health care products. The pharmaceutical commercial business is mainly engaged in pharmaceutical commercial wholesale business and pharmaceutical commercial retail business. The Company's products mainly include zinc gluconate oral solution, calcium iron zinc oral solution, compound calcium gluconate oral solution, amoxicillin capsules and Shuanghuanglian oral solution. The Company's products are mainly used in digestive, respiratory, anti-infectious, cardiovascular and cerebrovascular and anti-tumor treatment fields.
Employees
10,039
Date Price Change Volume
26-07-20 CN¥5.310 -0.38% 741,867,065
26-07-17 CN¥5.330 +7.89% 874,045,590
26-07-16 CN¥4.940 +10.02% 296,786,688
26-07-15 CN¥4.490 +10.05% 111,552,313
26-07-14 CN¥4.080 +9.97% 440,283,507
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
5.310CNY
Average target price
4.310CNY
Spread / Average Target
-18.83%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 600664 Stock